Trials / Completed
CompletedNCT03090542
GPur- Luminating Oral Cholesterol Kinetics Pilot Study
39 Day Randomized, Open Label, Two Arm Cross Over Study of Clinoptilolite (Gpur) in Healthy Adult Subjects Not Requiring or Receiving Lipid Lowering Therapy
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 22 (actual)
- Sponsor
- Canadian Collaborative Research Network · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
In healthy subjects not receiving or requiring lipid lowering therapy and who do not have diabetes, the use of clinoptilolite (GPUR) will result in a reduction of absorbed dietary cholesterol observed over 6 days of therapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | clinoptilolite | randomized, open-label, cross-over study of control vs clinoptilolite with a washout period separating the 2 phases |
Timeline
- Start date
- 2017-06-01
- Primary completion
- 2017-11-30
- Completion
- 2018-01-15
- First posted
- 2017-03-24
- Last updated
- 2018-01-25
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03090542. Inclusion in this directory is not an endorsement.